Prospective Monitoring of New Drugs in Older Adults with and without Frailty: Near-Real-Time Assessment of Effectiveness and Safety of Oral Anticoagulants in Medicare Data
Our frailty-specific sequential analyses can be applied to future near-real-time monitoring of newly approved drugs.
Authors
- Dae Hyun Kim (ORCID: https://orcid.org/0000-0001-7290-6838)
- Susan C. Cheng (ORCID: https://orcid.org/0000-0002-4977-036X)
- Sachin J. Shah (ORCID: https://orcid.org/0000-0001-8400-6888)
- Zhigang Lu
- Robert J. Glynn (ORCID: https://orcid.org/0000-0002-0697-8996)
- Kueiyu Joshua Lin (ORCID: https://orcid.org/0000-0003-4564-3715)
- Darae Ko (ORCID: https://orcid.org/0000-0002-1174-7535)
- Su Been Lee (ORCID: https://orcid.org/0000-0002-3437-097X)
Institutions
- Cedars-Sinai Medical Center (US)
- Brigham and Women's Hospital (US)
- Boston Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Hebrew SeniorLife (US)
Publication Details
- Journal
- Drugs & Aging
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1007/s40266-024-01142-9
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Brigham and Women's Hospital
- Boston Scientific Corporation
- Amarin Corporation
- Kowa Company
- National Institutes of Health
- National Institute on Aging
- National Heart, Lung, and Blood Institute